XML 71 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Convertible Promissory Notes - Additional Information (Detail) (USD $)
1 Months Ended 3 Months Ended 12 Months Ended 119 Months Ended 122 Months Ended 1 Months Ended 3 Months Ended 12 Months Ended 1 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 1 Months Ended 3 Months Ended 3 Months Ended 1 Months Ended
Feb. 28, 2013
Jan. 23, 2013
Jan. 29, 2013
Jan. 31, 2013
Jul. 25, 2012
Mar. 31, 2013
Dec. 31, 2012
Dec. 31, 2012
Mar. 31, 2013
Jul. 25, 2012
Minimum
Feb. 28, 2013
Conversion of notes to preferred stock then to common stock
Jan. 23, 2013
Subsequent Event
Jan. 29, 2013
Subsequent Event
Mar. 31, 2013
Common Stock
Dec. 31, 2010
Common Stock
Dec. 31, 2004
Common Stock
Feb. 28, 2013
Convertible debt
Jan. 23, 2013
Convertible debt
Jul. 25, 2012
Convertible debt
Feb. 28, 2013
Convertible debt
Common Stock
Dec. 31, 2012
Warrant Liability
Feb. 28, 2013
January 2013 Notes
Mar. 31, 2013
January 2013 Notes
Feb. 28, 2013
January 2013 Notes
Common Stock
Mar. 31, 2013
July 2012 Notes
Mar. 31, 2013
Option and License Agreement
Feb. 28, 2013
Option and License Agreement
Subsequent Event
Jul. 25, 2012
Conversion of Notes into Series A Preferred Stock
Jul. 25, 2012
Conversion of Notes into Series A Preferred Stock
To partially fund, or an option to partner with Opexa
Jul. 25, 2012
Conversion of Notes into Series A Preferred Stock
Additional capital from any partner, potential partner or any other source
Jul. 25, 2012
Conversion of Series A Convertible Preferred Stock into common stock
Jul. 25, 2012
Related Party Transactions
Mar. 31, 2013
Related Party Transactions
Jan. 31, 2013
Related Party Transactions
Dec. 31, 2012
Related Party Transactions
Warrant Liability
Mar. 31, 2013
Related Party Transactions
July 2012 Notes
Mar. 31, 2013
Related Party
Jan. 23, 2013
Related Party
Convertible debt
Debt Instrument [Line Items]                                                                            
Convertible secured promissory notes, principal amount         $ 4,085,000                                                     $ 630,000   $ 100,000        
Debt Instrument, Maturity Date         Jul. 25, 2014                         Jan. 23, 2014                                        
Debt instrument interest payment date description         Interest is payable semi-annually on June 30 and December 31 in either cash or registered shares of common stock, at Opexa's election.                                                                  
Convertible debt instrument, effective interest rate                                   12.00% 12.00%                                      
Convertible debt, conversion price         $ 100.00                         $ 1.30                                        
Milestone to elect to convert Notes into Series A convertible preferred stock, minimum                                                         5,000,000 25,000,000                
Minimum common stock price required for 20 consecutive trading days to elect to convert                                                       $ 10.00     $ 16.00              
Conversion of Notes to Series A convertible preferred stock, description                                                       The Notes can be converted into Series A convertible preferred stock at the option of the investors at a price of $100.00 per share, subject to certain limitations and adjustments. Additionally, Opexa can elect to convert the Notes into Series A convertible preferred stock if (i) Opexa’s common stock closes at or above $10.00 per share for 20 consecutive trading days or (ii) Opexa achieves certain additional funding milestones to continue its clinical trial program. These milestones include (x) executing a strategic agreement with a partner or potential partner by which Opexa will receive a minimum of $5 million to partially fund, or an option to partner with Opexa for, its Phase II clinical trial for Tcelna in patients with SPMS and (y) receiving a minimum of $25 million in additional capital (including the Note offering proceeds) from any partner, potential partner or any other source.                    
Series A Convertible Preferred Stock, dividend rate         8.00%                                                                  
Dividend payment description         The Series A convertible preferred stock accrues dividends at the rate of 8% per annum, which are cumulative and payable semi-annually on June 30 and December 31 in either cash or registered shares of common stock at Opexa's election.                                                                  
Series A Convertible Preferred Stock, Liquidation Preference         $ 100.00                                                                  
Conversion of preferred stock into common stock, price per share         $ 3.12                                                                  
Debt Conversion, Description                                                             Additionally, Opexa can elect to convert the Series A convertible preferred stock into common stock if the Company's common stock closes at or above $16.00 per share for 20 consecutive trading days.              
Convertible notes, principal amount converted                     900,000           900,000         100,000                                
Restricted cash           500,000 1,000,000 1,000,000 500,000       500,000                                                  
Debt instrument, beneficial conversion feature       141,829 1,497,634 141,829                                                   230,969 21,820          
Warrants issued         957,422                                                                  
Warrants exercise price $ 3.00 $ 1.24 $ 1.21   $ 5.00         $ 2.56   $ 1.24 $ 1.21                                                  
Warrants term 4 years 5 years 5 years   5 years             5 years 5 years                                                  
Warrant excercise terms subject to antidilution adjustment description         As a result of the antidilution adjustment, the number of warrant shares for which the Series I warrant is exercisable was subject to an aggregate increase to 1,436,121 shares of Opexa’s common stock at an adjusted exercise price of $2.56 per share, subject to certain limitations and adjustments. Opexa can redeem the warrants at $0.01 per share if its common stock closes at or above $10.00 per share for 20 consecutive trading days. As a result, Opexa accounted for these reset provisions in accordance with Accounting Standards Codification (“ASC”) ASC 815-40, which requires Opexa to record the warrants as a derivative liability at the grant date and to record changes in fair value relating to the warrants at each subsequent balance sheet date.                                                                  
Warrant redemption per share description   Opexa can redeem the warrants at $0.01 per share if the Company's common stock closes at or above $10.00 per share for 20 consecutive trading days. The warrants at $0.01 per underlying share of common stock if the common stock closes at or above $10.00 per share for 20 consecutive trading days.   Opexa can redeem the warrants at $0.01 per share if its common stock closes at or above $10.00 per share for 20 consecutive trading days.             The Company can redeem the warrants at $0.01 per share if the Company’s common stock closes at or above $10.00 per share for 20 consecutive trading days. The Company can redeem the warrants at $0.01 per underlying share of common stock if the common stock closes at or above $10.00 per share for 20 consecutive trading days.                                                  
Discount on warrant       195,969 2,314,635 195,969 2,314,635 5,974,372 6,170,341                                                          
Amortized debt discount                                         104,032                           16,044      
Gain (loss) on derivative instruments             552,978 1,941,826 1,941,826                       552,978                                  
Convertible debt, unamortized discount             3,708,237 3,708,237                                               587,939            
Gross proceed from the issuance of a convertible note                                   650,000                                       100,000
Minimum receipt of proceeds from sale of equity securities and/or as payments from partners to pay any remaining balance of note payable                                   7,500,000                                        
Number of business days to pay remaining convertible debts                                   5 days                                        
Warrants issued       243,750   187,500     187,500                                                          
Gross proceeds from sales of common stock and warrants to purchase common stock           3,250,000                                                                
Option and License Agreement, upfront payment received                                                   5,000,000 5,000,000                      
Principal and interest paid           567,368                                                             100,000  
Common shares issued, note conversion           365,263               365,263 690,045 15,187               77,034                            
Convertible notes, amortized debt discount           1,237,662 104,032 6,856,730 8,094,392                           337,798                              
Common shares issued                                       288,229                                    
Long term liabilities                                                 $ 3,185,000                     $ 630,000